Cracking a Cold Case

Steven Francis, a patient at McGill University Health Centre, was at the center of a mystery. From an early age he had experienced fungal infections, an inflamed colon, shingles, respiratory problems, impeded growth, and a host of other problems. But no one could explain why. At 33, he was referred to Donald Vinh, who went searching for answers. “When this patient was referred to me, I went over his entire file in detail, covering some 30 years and literally filling two large cardboard boxes. I also looked at his family history. Since the 1980s, many new immune deficiencies have been identified, and I was able to apply the knowledge from these advances to solve the case,” he says.

And solve it he did – discovering that Steven had a mutation in ZAP70. The ZAP-70 protein helps to activate T cells and is critical for immune system function – and usually, mutations of the gene require a hematopoietic stem cell transplant for the patient to survive beyond early childhood. “Leaky” deficiencies in the gene are less common, with only a few cases reported in the literature. As stem cell transplants could prove risky for older patients, Vinh and his colleagues looked at a different approach: mutation-targeted molecular therapy.  Steven’s specific mutation affects the splicing of ZAP-70, so the team designed an antisense morpholino oligonucleotide that targets the splice site generated by the mutation. This allowed the protein to be successfully synthesized ex vivo. If the treatment can be translated to humans,  it could potentially improve immune system function. Vinh is hopeful that the discovery of ZAP70 mutations in adults, and the proof-of-concept study of a potential treatment, could lead to great advances in the field. “There are definitely more steps to take before we can test this treatment. For one thing, we have to convince the industry to support us. When Steven can finally get the benefit of the treatment, I’ll be able to count this as a victory,” he adds.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

I have read and understand the Privacy Notice*

Subscribe

References

1. C Gavino et al., “Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency” J Allergy Clin Immunol, 139, 1688–1692 (2017). PMID: 28216435.

About the Author(s)

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as an Associate Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

More Articles by Roisin McGuigan